| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
167,977 |
156,747 |
$21.30M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
156,829 |
96,244 |
$2.30M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
45,346 |
29,833 |
$612K |
| 90832 |
Psychotherapy, 30 minutes with patient |
10,156 |
5,034 |
$342K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,858 |
4,158 |
$226K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,280 |
3,850 |
$204K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
11,247 |
6,485 |
$165K |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
9,025 |
6,303 |
$154K |
| 90791 |
Psychiatric diagnostic evaluation |
1,928 |
1,231 |
$151K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15,761 |
11,706 |
$149K |
| 96127 |
|
52,643 |
35,574 |
$133K |
| 99201 |
|
2,107 |
1,531 |
$99K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,785 |
2,152 |
$94K |
| 90746 |
|
1,425 |
1,277 |
$79K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,642 |
1,500 |
$62K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
3,187 |
1,948 |
$61K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,439 |
700 |
$61K |
| G9012 |
Other specified case management service not elsewhere classified |
560 |
260 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,470 |
8,870 |
$38K |
| 90686 |
|
6,606 |
4,869 |
$32K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,360 |
785 |
$30K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,457 |
917 |
$29K |
| 0011A |
|
417 |
415 |
$27K |
| 90715 |
|
1,380 |
1,075 |
$25K |
| 98940 |
|
1,460 |
1,157 |
$18K |
| 81025 |
|
10,506 |
6,941 |
$17K |
| 81003 |
|
15,910 |
11,066 |
$16K |
| 99173 |
|
7,578 |
5,032 |
$14K |
| 0012A |
|
184 |
182 |
$12K |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
283 |
267 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
714 |
519 |
$8K |
| D1206 |
Topical application of fluoride varnish |
967 |
815 |
$8K |
| 0064A |
|
87 |
87 |
$6K |
| 97814 |
|
669 |
355 |
$4K |
| 87254 |
|
1,414 |
1,384 |
$4K |
| 90732 |
|
59 |
59 |
$4K |
| 82947 |
|
4,287 |
3,871 |
$3K |
| 97813 |
|
660 |
354 |
$2K |
| 92552 |
|
7,522 |
4,956 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,167 |
1,392 |
$2K |
| J3490 |
Unclassified drugs |
47 |
37 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,750 |
1,201 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
374 |
260 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,750 |
1,195 |
$1K |
| 69209 |
|
84 |
36 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
108 |
64 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
269 |
244 |
$976.44 |
| 99215 |
Prolong outpt/office vis |
138 |
71 |
$929.93 |
| 99385 |
|
139 |
88 |
$787.29 |
| 90632 |
|
15 |
15 |
$737.98 |
| 99000 |
|
297 |
181 |
$617.54 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
132 |
90 |
$426.48 |
| 87210 |
|
143 |
58 |
$390.07 |
| 99383 |
|
117 |
98 |
$307.57 |
| 85018 |
|
4,344 |
4,024 |
$250.62 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
25 |
$239.64 |
| 90651 |
|
974 |
710 |
$234.22 |
| 97811 |
|
18 |
15 |
$222.38 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
19 |
12 |
$214.74 |
| 90620 |
|
158 |
125 |
$165.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
9,339 |
8,216 |
$150.00 |
| 97810 |
|
18 |
15 |
$125.10 |
| 99384 |
|
43 |
30 |
$114.98 |
| 86580 |
|
24 |
23 |
$77.28 |
| 99381 |
|
12 |
12 |
$45.33 |
| 90688 |
|
128 |
128 |
$31.30 |
| 90670 |
|
772 |
582 |
$18.00 |
| 90744 |
|
356 |
269 |
$18.00 |
| 82962 |
|
133 |
116 |
$3.28 |
| 97012 |
|
4,106 |
3,113 |
$0.01 |
| 3077F |
|
3,774 |
3,400 |
$0.00 |
| 3078F |
|
32,053 |
29,652 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
227 |
206 |
$0.00 |
| 90734 |
|
608 |
434 |
$0.00 |
| 90633 |
|
604 |
485 |
$0.00 |
| 96160 |
|
271 |
257 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
98 |
96 |
$0.00 |
| 90710 |
|
101 |
79 |
$0.00 |
| 90707 |
|
43 |
30 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
45 |
42 |
$0.00 |
| 90685 |
|
21 |
21 |
$0.00 |
| 83037 |
|
57 |
50 |
$0.00 |
| 90648 |
|
50 |
50 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
12 |
12 |
$0.00 |
| 90700 |
|
13 |
13 |
$0.00 |
| 3079F |
|
10,175 |
9,315 |
$0.00 |
| 97010 |
|
6,547 |
4,616 |
$0.00 |
| 3075F |
|
4,696 |
4,337 |
$0.00 |
| 3074F |
|
35,371 |
32,618 |
$0.00 |
| 88142 |
|
386 |
209 |
$0.00 |
| 3080F |
|
1,497 |
1,350 |
$0.00 |
| 97032 |
|
1,385 |
1,121 |
$0.00 |
| 97014 |
|
864 |
758 |
$0.00 |
| 90698 |
|
379 |
274 |
$0.00 |
| 90656 |
|
76 |
74 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
340 |
291 |
$0.00 |
| 90723 |
|
29 |
29 |
$0.00 |
| 90716 |
|
92 |
69 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
14 |
13 |
$0.00 |
| 3008F |
|
18 |
17 |
$0.00 |
| 90696 |
|
44 |
25 |
$0.00 |
| 99386 |
|
21 |
13 |
$0.00 |
| 92551 |
|
18 |
18 |
$0.00 |
| 90619 |
|
24 |
15 |
$0.00 |
| 90677 |
|
19 |
14 |
$0.00 |